White Paper on HCQ 2020 - UTRGV

a twenty-year period, looking at almost one million patients, those taking HCQ did not have an increased risk of heart problems. It says: This is the largest ever analysis of the safety of such treatments worldwide, examining over 900,000 HCQ and more than 300,000 HCQ + azithromycin users respectively. ................
................